Answers are grounded in this paper and cite their sources.
I would like to reconsider a recent analysis by Prof. Senn on the statistics of the Pfizer-BioNTech vaccine trial, to express some different opinions and to clarify some theoretical points, especially regarding the clinical applications of Bayesian statistics.
No takes yet. Share an insight, caveat, or question.
Mauro Gasparini (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: